Robeco Institutional Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.9M | Sell |
|
|||||
|
2025
Q1 | $1.79M | Buy |
|
|||||
|
2024
Q4 | $2M | Sell |
|
|||||
|
2024
Q3 | $44.6M | Buy |
|
|||||
|
2024
Q2 | $46M | Buy |
|
|||||
|
2024
Q1 | $42.8M | Buy |
|
|||||
|
2023
Q4 | $23.4M | Buy |
|
|||||
|
2023
Q3 | $17.3M | Sell |
|
|||||
|
2023
Q2 | $14.6M | Sell |
|
|||||
|
2023
Q1 | $16.4M | Sell |
|
|||||
|
2022
Q4 | $22.5M | Buy |
|
|||||
|
2022
Q3 | $6.84M | Buy |
|
|||||
|
2022
Q2 | $861K | Buy |
|
|||||
|
2022
Q1 | $57K | Sell |
|
|||||
|
2021
Q4 | $294K | Buy |
|
|||||
|
2021
Q3 | $324K | Hold |
|
|||||
|
2021
Q2 | $329K | Hold |
|
|||||
|
2021
Q1 | $329K | Sell |
|
|||||
|
2020
Q4 | $392K | Hold |
|
|||||
|
2020
Q3 | $393K | Buy |
|
|||||
|
2020
Q2 | $15K | Sell |
|
|||||
|
2020
Q1 | $290K | Buy |
|
|||||
|
2019
Q4 | $52K | Buy |
|